Articles about Biotechnology, Pharmaceutical and Healthcare

00:19 EDT 25th October 2014 | BioPortfolio

Latest Articles on life science, biotechnology, pharmaceutical and healthcare topics and current issues.

Showing News Articles 1–25 of 39,000+

Friday 24th October 2014

[Articles] Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial

Cognitive function is not affected by short-term dual antiplatelet treatment or blood pressure reduction in fairly young patients with recent lacunar stroke. Future studies of cognitive function after stroke should be of longer duration or focus on p...

[Comment] Blood pressure control after stroke: too little, too late, or too soon to tell?

Cognitive decline is among the most feared and common changes in late life, and prevention of cognitive decline in any population is a worthy goal. In The Lancet Neurology, Lesly Pearce and colleagues report results of a prespecified secondary outcom...

[Articles] Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis

The number of beds at EVD treatment centres needed to effectively control EVD in Montserrado substantially exceeds the 1700 pledged by the USA to west Africa. Accelerated case ascertainment is needed to maximise effectiveness of expanding the capacit...

[Comment] Ebola: no time to waste

“I wasted time, and now doth time waste me”William Shakespeare, King Richard II

Margaret McCartney: Dementiagate--how politicised pay diverts GPs from working for patients

I’m wondering if this is Dementiagate—a defining moment when the UK public discovers the ugly truth about how most GPs are paid. The news from NHS England, that GPs were to receive £55 (€70; $90) for...

Drug company is targeted for refusing to adopt ban on distribution of execution drug

A US drug company has been targeted by investors after declining to participate fully in the embargo against providing lethal injection drugs to states with the death penalty.The company, Mylan, of...

Vaccine tests to begin in Ebola countries this year

Trials of two candidate Ebola vaccines have been fast tracked and will now begin in west Africa in December, the World Health Organization has said.A meeting of officials from the affected countries,...

Cancer Innovation Forum Calls for Improving Research Progress

At a time when cancer drug development is at a critical juncture, accelerating the delivery of promising new treatments will depend on one critical requirement: ensuring that patients, individually and collectively, are actively involved in the cancer research and drug development process from beginning to end.  This was the consensus of leading scientists, advocates and government officials mee...

News and press releases: Regulatory update - Changes to scientific advice procedures as of 17 November 2014

As of 17 November 2014, the European Medicines Agency is introducing changes to the procedures for scientific advice, parallel advice with health technology assessment (HTA) bodies, protocol assistance and qualification of novel methodologies.

Newly Released Dallas Nurse to Meet With Obama

Read more about Newly Released Dallas Nurse to Meet With ObamaComments

AstraZeneca's Cancer Drug Gets Positive CHMP Review

AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the marketing authorisation of Lynparza (olaparib) as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopia...

Arbor Pharmaceuticals Announces FDA New Drug Approval

Arbor Pharmaceuticals announced that the FDA has approved its New Drug Application (NDA) for Sotylize (sotalol hydrochloride) oral solution. Sotylize is the first and only sotalol oral solution indicated for the treatment of documented life-threatening ventricular arrhythmias and the maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation/flutter.Read...

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Revision: 17, Authorised

Baxter Announces FDA Approval For New Hemophilia Drug

Read more about Baxter Announces FDA Approval For New Hemophilia DrugComments

Can Video Games Curb Racism?

Many Americans love to celebrate bone-crunching athletic games such as football that encourage strong social bonds among teammates of all skin colors. The idea of team games helping to cross racial barriers may also apply to violent video games that ...

News and press releases: Regulatory update - EMA encourages companies to submit quality type I variations for 2014 by end of November

The European Medicines Agency (EMA) is advising marketing authorisation holders to submit any type IAIN and type IA variations for 2014 by Friday 28 November wherever possible.

News and press releases: Regulatory update – All referral procedures to be sent via eSubmission Gateway / Web Client from 1 November 2014

Companies subject to a referral procedure for human medicines should send all their submissions via the eSubmission Gateway or the Web Client from 1 November 2014.

Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Revision: 9, Authorised

Hepatitis B Reagents

ViroStat has expanded its offering of hepatitis B reagents including its MONOTOPE and OMNITOPE antibodies and Recombinant Antigens. Specificities include surface antigen (HBsAg), HB core, HB “e,” pre-S1, pre-S2 and HB-X. Applications for these reagents include ELISA, WB, IHC and rapid tests. ViroStat, www.virostat-inc.com

Proteins Direct Precursors of Pyramidal Cells to Their Destination

Read more about Proteins Direct Precursors of Pyramidal Cells to Their Destination

New Weight Loss Regulation Clues Discovered

A hormone seen as a popular target to develop weight loss drugs works by directly targeting the brain and triggering previously unknown activity in the nervous system, UT Southwestern Medical Center obesity researchers have found.  

Researchers Find New Target for Treating Childhood Cancers

Scientists at the University of Liverpool have uncovered a new target for drugs that could battle a lethal childhood cancer known as neuroblastoma.Neuroblastoma is one of the deadliest childhood cancers, causing 15% of all paediatric cancer deaths.  The majority of sufferers have incurable disease, which has often spread throughout the body when first diagnosed.

Myriad Establishes New Tumor Research Lab in Europe

Myriad Genetics Inc. announced it has established a Tumor BRACAnalysis CDx laboratory in Europe. Myriad's next-generation Tumor BRACAnalysis CDx test is a companion diagnostic that will identify up to 50% more patients with BRAC mutations who may benefit from treatment with PARP inhibitors, such as olaparib, compared to conventional germline testing alone.Read more about Myriad Establishes New Tum...

Study Finds Best Way to Treat Neck Pain

A multicenter study of 169 men and women with a common form of neck pain suggests that both spinal steroid injections and conservative treatment with physical therapy and painkillers work equally well to relieve pain in the short term. But over time, a combination of the two appears to offer the most relief.    

Five More Ebola Vaccines To Be Tested in March

Read more about Five More Ebola Vaccines To Be Tested in March


Search BioPortfolio:
Loading
Advertisement
Advertisement